“Mölnlycke” Granulox Woundspray - Taiwan Registration dc5b23077a23e3d422fee33563a56aea
Access comprehensive regulatory information for “Mölnlycke” Granulox Woundspray in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number dc5b23077a23e3d422fee33563a56aea and manufactured by Hälsa Pharma GmbH. The authorized representative in Taiwan is MOLNLYCKE HEALTH CARE TAIWAN CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
dc5b23077a23e3d422fee33563a56aea
Ministry of Health Medical Device Import No. 030980
DHA05603098005
Product Details
This product is suitable for the treatment of chronic wounds, such as venous ulcers on the legs, arterial ulcers, mixed ulcers, diabetic foot ulcers, secondary healing surgical wounds, and pressure injuries (pressure ulcers), and can also be used for wounds of debridement of carrion and infectious tissues.
I General and plastic surgical devices
Imported from abroad
Dates and Status
Jun 13, 2018
Jun 13, 2028